Zomedica Pharmaceuticals Corp Stock Today
| ZOM Stock | USD 0.13 0.01 7.14% |
Performance2 of 100
| Odds Of DistressLess than 23
|
Zomedica Pharmaceuticals is selling at 0.13 as of the 18th of April 2024; that is -7.14 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.13. Zomedica Pharmaceuticals has about a 23 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Zomedica Pharmaceuticals Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of September 2022 and ending today, the 18th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 29th of July 2016 | Category Healthcare | Classification Health Care |
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan. Zomedica Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on AMEX Exchange. The company has 979.95 M outstanding shares of which 63.99 M shares are at this time shorted by investors with about 11.47 days to cover. More on Zomedica Pharmaceuticals Corp
Follow Valuation Profit Patterns Odds of Bankruptcy
Financial Report 9th of May 2024
Zomedica Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Zomedica Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Zomedica Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Robert Cohen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Name | Zomedica Pharmaceuticals Corp | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Zomedica Pharmaceuticals report their recommendations after researching Zomedica Pharmaceuticals' financial statements, talking to executives and customers, or listening in on Zomedica Pharmaceuticals' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Zomedica Pharmaceuticals. The Zomedica consensus assessment is calculated by taking the average forecast from all of the analysts covering Zomedica Pharmaceuticals. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Zomedica Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Zomedica Pharmaceuticals Corp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in May. Financial strength of Zomedica Pharmaceuticals is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Zomedica Pharmaceuticals' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Zomedica Pharmaceuticals' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Zomedica Pharmaceuticals' financial leverage. It provides some insight into what part of Zomedica Pharmaceuticals' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Zomedica Pharmaceuticals Corp (ZOM) is traded on NYSE MKT Exchange in USA. It is located in 100 Phoenix Drive, Ann Arbor, MI, United States, 48108 and employs 144 people. Zomedica Pharmaceuticals is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a total capitalization of 127.69 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Zomedica Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Zomedica Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Zomedica Pharmaceuticals runs under Pharmaceuticals sector within Health Care industry. The entity has 979.95 M outstanding shares of which 63.99 M shares are at this time shorted by investors with about 11.47 days to cover.
Zomedica Pharmaceuticals Corp has about 27.4 M in cash with (15.97 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Zomedica Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationZomedica Pharmaceuticals owns a total of 979.95 Million outstanding shares. Roughly 90.0 (%) of Zomedica Pharmaceuticals outstanding shares are held by general public with 1.59 % owned by insiders and only 8.88 percent by institutional investors. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Zomedica Ownership Details
Zomedica Stock Price Odds Analysis
Contingent on a normal probability distribution, the odds of Zomedica Pharmaceuticals jumping above the current price in 90 days from now is about 87.26%. The Zomedica Pharmaceuticals Corp probability density function shows the probability of Zomedica Pharmaceuticals stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon the stock has a beta coefficient of 1.9449. This usually means as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Zomedica Pharmaceuticals will likely underperform. Additionally, zomedica Pharmaceuticals Corp has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Zomedica Pharmaceuticals to move above the current price in 90 days from now is about 87.26 (This Zomedica Pharmaceuticals Corp probability density function shows the probability of Zomedica Stock to fall within a particular range of prices over 90 days) .
Zomedica Pharmaceuticals Historical Income Statement
Zomedica Pharmaceuticals Corp Income Statement is one of the three primary financial statements used for reporting Zomedica's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Zomedica Pharmaceuticals revenue and expense. Zomedica Pharmaceuticals Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Zomedica Pharmaceuticals' Cost Of Revenue is very stable compared to the past year. As of the 18th of April 2024, Interest Income is likely to grow to about 5.9 M, though EBIT is likely to grow to (30 M). View More FundamentalsZomedica Stock Against Markets
Picking the right benchmark for Zomedica Pharmaceuticals stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Zomedica Pharmaceuticals stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Zomedica Pharmaceuticals is critical whether you are bullish or bearish towards Zomedica Pharmaceuticals Corp at a given time. Please also check how Zomedica Pharmaceuticals' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Zomedica Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
| All Next | Launch Module |
Zomedica Pharmaceuticals Corporate Directors
Zomedica Pharmaceuticals corporate directors refer to members of a Zomedica Pharmaceuticals board of directors. The board of directors generally takes responsibility for the Zomedica Pharmaceuticals' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Zomedica Pharmaceuticals' board members must vote for the resolution. The Zomedica Pharmaceuticals board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Thomas Robitaille | Independent Director | Profile | |
| Tom Robitaille | Independent Director | Profile | |
| Johnny Powers | Independent Director | Profile | |
| Jane Eagleson | Independent Director | Profile |
How to buy Zomedica Stock?
Before investing in Zomedica Pharmaceuticals, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Zomedica Pharmaceuticals. To buy Zomedica Pharmaceuticals stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Zomedica Pharmaceuticals. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Zomedica Pharmaceuticals stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Zomedica Pharmaceuticals Corp stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Zomedica Pharmaceuticals Corp stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Zomedica Pharmaceuticals Corp, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Zomedica Stock please use our How to Invest in Zomedica Pharmaceuticals guide.
Already Invested in Zomedica Pharmaceuticals Corp?
The danger of trading Zomedica Pharmaceuticals Corp is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Zomedica Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Zomedica Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Zomedica Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Zomedica Pharmaceuticals is a strong investment it is important to analyze Zomedica Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Zomedica Pharmaceuticals' future performance. For an informed investment choice regarding Zomedica Stock, refer to the following important reports: Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zomedica Pharmaceuticals Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Complementary Tools for Zomedica Stock analysis
When running Zomedica Pharmaceuticals' price analysis, check to measure Zomedica Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zomedica Pharmaceuticals is operating at the current time. Most of Zomedica Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Zomedica Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zomedica Pharmaceuticals' price. Additionally, you may evaluate how the addition of Zomedica Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |
Is Zomedica Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zomedica Pharmaceuticals. If investors know Zomedica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zomedica Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.03) | Revenue Per Share 0.026 | Quarterly Revenue Growth 0.192 | Return On Assets (0.07) | Return On Equity (0.14) |
The market value of Zomedica Pharmaceuticals is measured differently than its book value, which is the value of Zomedica that is recorded on the company's balance sheet. Investors also form their own opinion of Zomedica Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Zomedica Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zomedica Pharmaceuticals' market value can be influenced by many factors that don't directly affect Zomedica Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zomedica Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Zomedica Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zomedica Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.